— Know what they know.
Not Investment Advice

EDXC OTC

Endexx Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -87.5% 1Y: -95.8% 3Y: -99.8% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $57185 mcap · 479M float · 0.150% daily turnover · Short 71% of daily vol

Income Trends

Revenue
$2M -57.6% ▼
5Y CAGR: +2.0%
Gross Profit
$731K +163.6% ▲
5Y CAGR: +1.6%
Operating Income
-$583K +88.9% ▲
Net Income
-$3M +47.7% ▲
EPS (Diluted)
$-0.01 +49.6% ▲
EBITDA
-$613K +86.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$2M$651K$2M$4M$2M
YoY Growth+31.6%-67.0%+228.7%+82.8%-57.6%
Cost of Revenue$607K$995K$775K$5M$925K
Gross Profit$1M-$344K$503K-$1M$731K
Gross Margin69.2%-52.9%23.5%-29.4%44.1%
R&D Expenses$15K$10K$27K$5K$3K
SG&A Expenses$4M$5M$4M$4M$1M
Operating Expenses$4M$5M$4M$4M$1M
Operating Income-$3M-$5M-$4M-$5M-$583K
Operating Margin-132.7%-825.7%-171.5%-134.1%-35.2%
Interest Expense$3M$951K$4M$4M$3M
Income Before Tax-$8M-$7M-$5M-$8M-$3M
Tax Expense$3M$0$0$0$0
Net Income-$8M-$7M-$5M-$6M-$3M
Net Margin-409.0%-1046.6%-229.0%-166.3%-205.2%
EPS (Diluted)$-0.03$-0.01$-0.01$-0.01$-0.01
EBITDA-$6M-$5M-$4M-$5M-$613K
Shares Outstanding379M455M504M505M521M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms